Unipril 1.25 mg tablet, manufactured by The ACME Laboratories Ltd., contains ramipril, an ACE inhibitor. It is prescribed for high blood pressure and certain heart conditions.
There are 42 brands of Ramipril listed in Bangladesh. 4 of them have a lower unit price than Unipril. The lowest listed price is Ramoril 1.25 mg Tablet at ৳ 2.5 per unit.
What is Unipril 1.25 mg Tablet?
Unipril is a brand of ramipril, an angiotensin-converting enzyme (ACE) inhibitor. It is available as a 1.25 mg tablet from The ACME Laboratories Ltd. This medicine is used to treat high blood pressure and heart failure, and may be used after a heart attack when heart failure signs appear. It works by blocking the formation of angiotensin II, a substance that narrows blood vessels, helping blood vessels relax and reducing the workload on the heart. Treatment is long-term and should be supervised by a doctor.
Uses of Unipril
Unipril is used to manage high blood pressure, either alone or with other blood pressure medicines. It is also used for congestive heart failure, often together with diuretics. Additionally, it may be prescribed for patients who show signs of heart failure within the first few days after a heart attack. Your doctor will determine if this medicine is suitable for your condition.
How to use Unipril
Take Unipril exactly as your doctor prescribes. The dose and how often you take it will be decided by your doctor based on your condition and response. Swallow the tablet with water, with or without food. Do not change the dose or stop taking it without talking to your doctor, even if you feel well. Regular follow-up is important to monitor your progress.
Side effects of Unipril
Unipril is generally well tolerated. Common side effects include dizziness, headache, tiredness, and weakness. Less frequent side effects are low blood pressure, cough, nausea, vomiting, diarrhoea, rash, hives, and reduced urine output. Rarely, serious allergic reactions such as angioedema (swelling of the face, lips, tongue, or throat) and high potassium levels can occur. Tell your doctor if you notice any side effects.
Safety and precautions
Unipril must not be used during pregnancy, as it can harm the unborn baby. Women who could become pregnant should use effective contraception and tell their doctor if they plan to become pregnant. It is not recommended while breastfeeding. Use with caution if you have kidney or liver problems, high potassium levels, or low blood pressure. Do not take Unipril if you have a history of angioedema or are taking sacubitril/valsartan. Inform your doctor about all medicines you take. Store below 30°C, protect from light, and keep out of reach of children.
Frequently asked questions
What are the side effects of Unipril and when should I call the doctor?
Common side effects include dizziness, headache, and tiredness. Call your doctor right away if you have swelling of the face, lips, tongue, or throat, difficulty breathing, or a severe drop in blood pressure. Also report a persistent cough or any unusual symptoms.
What is Unipril used for and what kind of medicine is it?
Unipril is an ACE inhibitor used to treat high blood pressure and heart failure, and may be used after a heart attack. It works by relaxing blood vessels and reducing the heart's workload.
How should I take Unipril?
Take Unipril exactly as your doctor prescribes. The dose and frequency are decided by your doctor based on your condition. Do not change or stop the medicine without consulting your doctor. Swallow the tablet with water.
Hypertension; to lower blood pressure, as single-drug therapy or in combination with other antihypertensive agents.
Congestive heart failure; also in combination with diuretics.
Treatment of patients who- within the first few days after an acute myocardial infarction- have demonstrated clinical signs of congestive heart failure.
... Read more
Ramipril indicated in the following cases:
Hypertension; to lower blood pressure, as single-drug therapy or in combination with other antihypertensive agents.
Congestive heart failure; also in combination with diuretics.
Treatment of patients who- within the first few days after an acute myocardial infarction- have demonstrated clinical signs of congestive heart failure.
Treatment of non-diabetic or diabetic overt glomerular or incipient nephropathy.
Reduction in the risk of myocardial infarction, stroke, or cardiovascular death in patients with an increased cardiovascular risk, such as manifest coronary heart disease (with or without a history of myocardial infarction), a history of stroke, a history of peripheral vascular disease, or diabetes mellitus that is accompanied by at least one other cardiovascular risk factor (microalbuminuria, hypertension, elevated total cholesterol levels, low high-density lipoprotein cholesterol levels, smoking).
Pharmacology
Ramipril is an angiotensin converting enzyme (ACE) inhibitor, which after hydrolysis to ramiprilat, blocks the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. So, inhibition of ACE by ramipril results in decreased plasma angiotensin II, which leads to decreased vasopressor activity and decreased aldosterone secretion. Thus ramipril exerts its antihypertensive activity. It is also effective in the management of heart failure and reduction of the risk of stroke, myocardial infarction and death from cardiovascular events. It is long acting and well tolerated; so, can be used in long term therapy.
Dosage & Administration
Dosage of Ramipril must be adjusted according to the patient tolerance and response.
Hypertension: For the management of hypertension in adults not receiving a diuretic, the usual initial dose of Ramipril is 1.25-2.5 mg once daily. Dosage generally is adjusted no more rapidly than at 2 week intervals. The usual maintenance dosage in adults is 2.5-20 mg daily given as a single dose or in 2 divided doses daily. If BP is not controlled with Ramipril alone, a diuretic may be added.
Congestive heart failure after myocardial infarction: In this case, Ramipril therapy may be initiated as early as 2 days after myocardial infarction. An initial dose of 2.5 mg twice daily is recommended, but if hypotension occurs, dose should be reduced to 1.25 mg twice daily. Therapy is then titrated to a target daily dose of 5 mg twice daily.
Prevention of major cardiovascular events: In this case, the recommended dose is 2.5 mg once daily for the first week of therapy and 5 mg once daily for the following 3 weeks; dosage then may be increased, as tolerated, to a maintenance dosage of 10 mg once daily.
Dosage in renal impairment:
For patients with hypertension and renal impairment: The recommended initial dose is 1.25 mg Ramipril once daily. Subsequent dosage should be titrated according to individual tolerance and BP response, up to a maximum of 5 mg daily.
For patients with heart failure and renal impairment: The recommended dose is 1.25 mg once daily. The dose may be increased to 1.25 mg twice daily and up to a maximum dose of 2.5 mg twice daily depending upon clinical response and tolerability.
Interaction
Concomitant administration with diuretics may lead to serious hypotension and in addition dangerous hyperkalemia with potassium sparing diuretics. Concomitant therapy with lithium may increase the serum lithium concentration. Reduction in BP may affect the ability to drive and operate machinery and this may be exacerbated by alcohol. NSAIDs may reduce the antihypertensive effect of Ramipril and cause deterioration of renal function.
Contraindications
Ramipril must not be used
in patients with hypersensitivity to ramipril, to any other ACE inhibitor, or any of the excipients of Ramipril.
in patients with a history of angioedema.
concomitantly with sacubitril/valsartan therapy. Do not initiate Ramipril until sacubitril/valsartan is eliminated from the body. In case of switch from Ramipril to sacubitril/valsartan, do not start sacubitril/valsartan until Ramipril is eliminated from the body.
in patients with haemodynamically relevant renal artery stenosis, bilateral or unilateral in the single kidney.
in patients with hypotensive or haemodynamically unstable states.
with aliskiren-containing medicines in patients with diabetes or with moderate to severe renal impairment (creatinine clearance <60 ml/min).
with angiotensin II receptor antagonists (AIIRAs) in patients with diabetic nephropathy.
during pregnancy.
Concomitant use of ACE inhibitors and extracorporeal treatments leading to contact of blood with negatively charged surfaces must be avoided, since such use may lead to severe anaphylactoid reactions. Such extracorporeal treatments include dialysis or haemofiltration with certain high-fux (e.g. polyacrylonitril) membranes and low-density lipoprotein apheresis with dextran sulfate.
Side Effects
Ramipril is generally well tolerated. Dizziness, headache, fatigue and asthenia are commonly reported side effects. Other side effects occurring less frequently include symptomatic hypotension, cough, nausea, vomiting, diarrhoea, rash, urticaria, oliguria, anxiety, amnesia etc. Angioneurotic oedema, anaphylactic reactions and hyperkalaemia have also been reported rarely.
Pregnancy & Lactation
Ramipril must not be taken during pregnancy. Therefore, pregnancy must be excluded before starting treatment. Pregnancy must be avoided in cases where treatment with ACE inhibitors is indispensable. If the patient intends to become pregnant, treatment with ACE inhibitors must be discontinued, i.e. replaced by another form of treatment. If the patient becomes pregnant during treatment, medication with Ramipril must be replaced as soon as possible by a treatment regimen without ACE inhibitors. Otherwise, there is a risk of harm to the fetus. Ramipril is not recommended during breastfeeding.
Precautions & Warnings
Ramipril should be used with caution in patients with impaired renal function, hyperkalaemia, hypotension, and impaired hepatic function.
Overdose Effects
Sign and symptom: Overdosage may cause excessive peripheral vasodilatation (with marked hypotension, shock), bradycardia, electrolyte disturbances, and renal failure.
Management: Primary detoxifcation by, for example, gastric lavage, administration of adsorbents, sodium sulfate; (if possible during the frst 30 minutes). In the event of hypotension administration of α1-adrenergic agonists (e.g. norepinephrine, dopamine) or angiotensin II (angiotensinamide), which is usually available only in scattered research laboratories, must be considered in addition to volume and salt substitution.
Storage Conditions
Store at 30° or below, protect from light. Keep out of the reach of children. Do not use later than the date of expiry. To be dispensed only on the prescription of a registered physician.
Alternative brands of Ramipril
Other brands with the same generic name, cheapest first.